Natural progression model of cognition and physical functioning among people with mild cognitive impairment and Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 37, Issue 2, 2013, Pages 357-365

  Handels, Ron L H ^a   Xu, Weili ^b   Rizzuto, Debora ^b   Caracciolo, Barbara ^b,c   Wang, Rui ^b   Winblad, Bengt ^b   Verhey, Frans R J ^a   Severens, Johan L ^d   Fratiglioni, Laura ^b,e   Joore, Manuela A ^f   Wimo, Anders ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Alzheimer's disease; dementia; disease progression; economic model; mild cognitive impairment

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; EDUCATION; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HUMAN; KATZ INDEX; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; SURVIVAL; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COHORT STUDIES; COMMUNITY HEALTH PLANNING; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MILD COGNITIVE IMPAIRMENT; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; SURVIVAL ANALYSIS; SWEDEN; TIME FACTORS;

EID: 84883785077     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130296     Document Type: Article

References (29)

1. Andrieu S, Coley N, Aisen P, Carrillo MC, DeKosky S, Durga J, Fillit H, Frisoni GB, Froelich L, Gauthier S, Jones R, Jönsson L, Khachaturian Z, Morris JC, Orgogozo J-M, Ousset P-J, Robert P, Salmon E, Sampaio C, Verhey F, Wilcock G, Vellas B (2009) Methodological issues in primary prevention trials for neurodegenerative dementia. J Alzheimers Dis 16, 235-270.
2. Cohen JT, Neumann PJ (2008) Decision analytic models for Alzheimer's disease: State of the art and future directions. Alzheimers Dement 4, 212-222.
3. Schaafsma JD, Van Der Graaf Y, Rinkel GJE, Buskens E (2009) Decision analysis to complete diagnostic research by closing the gap between test characteristics and costeffectiveness. Clin Epidemiol 62, 1248-1252.
4. Brennan A, Chick SE, Davies R (2006) A taxonomy of model structures for economic evaluation of health technologies. Health Econ 15, 1295-1310.
5. Green C, Shearer J, Ritchie CW, Zajicek JP (2011) Modelbased economic evaluation in Alzheimer's disease: A review of the methods available to model Alzheimer's disease progression. Value Health 14, 621-630.
6. Fratiglioni L, Viitanen M, Bäckman L, Sandman PO, Winblad B (1992) Occurrence of dementia in advanced age: The study design of theKungsholmen Project. Neuroepidemiology 11(Suppl 1), 29-36.
7. Fratiglioni L, Viitanen M, Von Strauss E, Tontodonati V, Herlitz A, Winblad B (1997) Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen Project, Stockholm. Neurology 48, 132-138.
8. American Psychiatric Association, ed. (1987) Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R, American Psychiatric Association, Washington D.C.
9. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
10. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 185, 914-919.
11. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafström M, Holmen K, Ericsson K, Bäckman L, Ahlbom A, Winblad B (1991) Prevalence of Alzheimer's disease and other dementias in an elderly urban population: Relationship with age, sex, and education. Neurology 41, 1886-1892.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 77, 939- 944.
13. Roḿan GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260.
14. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308.
15. Petersen RC, Morris JC (2005) Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 62, 1160- 1163; discussion 1167.
16. Wahlin A, Bäckman L, Winblad B (1995) Free recall and recognition of slowly and rapidly presented words in very old age: A community-based study. Exp Aging Res 21, 251-271.
17. Caracciolo B, Palmer K, Monastero R, Winblad B, Bäckman L, Fratiglioni L (2008) Occurrence of cognitive impairment and dementia in the community: A 9-year-long prospective study. Neurology 70, 1778-1785.
18. Mitchell AJ, Shiri-Feshki M (2009) Rate of progression of mild cognitive impairment to dementia-meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 119, 252-265.
19. Palmer K, Wang H-X, Bäckman L, Winblad B, Fratiglioni L (2002) Differential evolution of cognitive impairment in nondemented older persons: Results from the Kungsholmen Project. Am J Psychiatry 159, 436-442.
20. Ruitenberg A, Kalmijn S, De Ridder MA, Redekop WK, Van Harskamp F, Hofman A, Launer LJ, Breteler MM (2001) Prognosis of Alzheimer's disease: The Rotterdam Study. Neuroepidemiology 20, 188-195.
21. McDonnell J, Redekop WK,Van Der Roer N, Goes E, Ruitenberg A, Busschbach JJ, Breteler MM, Rutten FF (2001) The cost of treatment of Alzheimer's disease in The Netherlands: A regression-based simulation model. Pharmacoeconomics 19, 543-550.
22. Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA (2000) Modelling mini mental state examination changes in Alzheimer's disease. Stat Med 19, 1607-1616.
23. Mohs RC, Schmeidler J, AryanM(2000) Longitudinal studies of cognitive, functional and behavioural change in patients with Alzheimer's disease. Stat Med 19, 1401-1409.
24. Han L, Cole M, Bellavance F, McCusker J, Primeau F (2000) Tracking cognitive decline in Alzheimer's disease using the mini-mental state examination: A meta-analysis. Int Psychogeriatr 12, 231-247.
25. Qiu C, Bäckman L,Winblad B, Agüero-Torres H, Fratiglioni L (2001) The influence of education on clinically diagnosed dementia incidence and mortality data from theKungsholmen Project. Arch Neurol 58, 2034-2039.
26. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, Copeland JR, Dartigues JF, Jagger C, Martinez-Lage J, Soininen H, HofmanA(2000) Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54, S10-S15.
27. Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, Wilkinson D, Waldemar G, Zhang R, Schindler R (2010) Predicting cognitive decline in Alzheimer's disease: An integrated analysis. Alzheimers Dement 6, 431-439.
28. Handels RL, Aalten P, Wolfs CA, Olde Rikkert M, Scheltens P, Visser PJ, Joore MA, Severens JL, Verhey FR (2012) Diagnostic and economic evaluation of new biomarkersfor Alzheimer's disease: The research protocol of a prospective cohort study. BMC Neurol 12, 72.
29. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, De Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, TierneyMC, Whitehouse P,Winblad B. (2006) Mild cognitive impairment. Lancet 367, 1262-1270.